1
|
Reichel JM, Bedenk BT, Gassen NC, Hafner K, Bura SA, Almeida-Correa S, Genewsky A, Dedic N, Giesert F, Agarwal A, Nave KA, Rein T, Czisch M, Deussing JM, Wotjak CT. Beware of your Cre-Ation: lacZ expression impairs neuronal integrity and hippocampus-dependent memory. Hippocampus 2016; 26:1250-64. [PMID: 27101945 DOI: 10.1002/hipo.22601] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/08/2016] [Indexed: 12/28/2022]
Abstract
Expression of the lacZ-sequence is a widely used reporter-tool to assess the transgenic and/or transfection efficacy of a target gene in mice. Once activated, lacZ is permanently expressed. However, protein accumulation is one of the hallmarks of neurodegenerative diseases. Furthermore, the protein product of the bacterial lacZ gene is ß-galactosidase, an analog to the mammalian senescence-associated ß-galactosidase, a molecular marker for aging. Therefore we studied the behavioral, structural and molecular consequences of lacZ expression in distinct neuronal sub-populations. lacZ expression in cortical glutamatergic neurons resulted in severe impairments in hippocampus-dependent memory accompanied by marked structural alterations throughout the CNS. In contrast, GFP expression or the expression of the ChR2/YFP fusion product in the same cell populations did not result in either cognitive or structural deficits. GABAergic lacZ expression caused significantly decreased hyper-arousal and mild cognitive deficits. Attenuated structural and behavioral consequences of lacZ expression could also be induced in adulthood, and lacZ transfection in neuronal cell cultures significantly decreased their viability. Our findings provide a strong caveat against the use of lacZ reporter mice for phenotyping studies and point to a particular sensitivity of the hippocampus formation to detrimental consequences of lacZ expression. © 2016 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- J M Reichel
- Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.,Department of Molecular Pharmacology, Albert Einstein College of Medicine, 10461, Bronx, New York
| | - B T Bedenk
- Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.,Core Unit Neuroimaging, Max Planck Institute of Psychiatry, 80804, Munich, Germany
| | - N C Gassen
- Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, 80804, Munich, Germany
| | - K Hafner
- Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, 80804, Munich, Germany
| | - S A Bura
- Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany
| | - S Almeida-Correa
- Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany
| | - A Genewsky
- Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany
| | - N Dedic
- Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany
| | - F Giesert
- Institute of Developmental Genetics, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health (GmbH), Ingolstaedter Landstrasse 1, Neuherberg, D-85764, Germany
| | - A Agarwal
- The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, Maryland
| | - K-A Nave
- Department of Neurogenetics, Max Planck Institute of Experimental Medicine, Goettingen, 37075, Germany
| | - T Rein
- Department of Translational Research in Psychiatry, Max Planck Institute of Psychiatry, 80804, Munich, Germany
| | - M Czisch
- Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.,Core Unit Neuroimaging, Max Planck Institute of Psychiatry, 80804, Munich, Germany
| | - J M Deussing
- Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany
| | - C T Wotjak
- Department of Stress Neurobiology and Neurogenetics, Max Planck Institute of Psychiatry, 80804, Munich, Germany.
| |
Collapse
|
2
|
Santos T, Carvalho J, Corvo MC, Cabrita EJ, Queiroz JA, Cruz C. L-tryptophan and dipeptide derivatives for supercoiled plasmid DNA purification. Int J Biol Macromol 2016; 87:385-96. [PMID: 26952704 DOI: 10.1016/j.ijbiomac.2016.02.079] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2015] [Revised: 02/28/2016] [Accepted: 02/29/2016] [Indexed: 12/30/2022]
Abstract
The present study focus on the preparation of chromatography supports for affinity-based chromatography of supercoiled plasmid purification. Three l-tryptophan based supports are prepared through immobilization on epoxy-activated Sepharose and characterized by HR-MAS NMR. The SPR is employed for a fast screening of l-tryptophan derivatives, as potential ligands for the biorecognition of supercoiled isoform, as well as, to establish the suitable experimental conditions for the chromatography. The results reveal that the overall affinity is high (KD=10(-9) and 10(-8)M) and the conditions tested show that the use of HEPES 100mM enables the separation and purification of supercoiled at T=10°C. The STD-NMR is performed to accomplish the epitope mapping of the 5'-mononucleotides bound to l-tryptophan derivatives supports. The data shows that the interactions between the three supports and the 5'-mononucleotides are mainly hydrophobic and π-π stacking. The chromatography experiments are performed with l-tryptophan support and plasmids pVAX-LacZ and pPH600. The supercoiled isoform separation is achieved at T=10°C by decreasing the concentration of (NH4)2SO4 from 2.7 to 0M in HEPES for pVAX-LacZ and 2.65M to 0M in HEPES for pPH600. Overall, l-tryptophan derivatives can be a promising strategy to purify supercoiled for pharmaceutical applications.
Collapse
Affiliation(s)
- Tiago Santos
- CICS-UBI-Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal
| | - Josué Carvalho
- CICS-UBI-Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal
| | - Marta C Corvo
- UCIBIO, REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal; CENIMAT/I3N, Departamento de Ciência dos Materiais, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal
| | - Eurico J Cabrita
- UCIBIO, REQUIMTE, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal
| | - J A Queiroz
- CICS-UBI-Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal
| | - C Cruz
- CICS-UBI-Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
| |
Collapse
|
3
|
Amorim LFA, Sousa F, Queiroz JA, Cruz C, Sousa Â. Screening ofl-histidine-based ligands to modify monolithic supports and selectively purify the supercoiled plasmid DNA isoform. J Mol Recognit 2015; 28:349-58. [DOI: 10.1002/jmr.2449] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2014] [Revised: 11/13/2014] [Accepted: 11/14/2014] [Indexed: 01/06/2023]
Affiliation(s)
- Lúcia F. A. Amorim
- CICS-UBI - Centro de Investigação em Ciências da Saúde; Universidade da Beira Interior; Av. Infante D. Henrique Covilhã 6200-506 Portugal
| | - Fani Sousa
- CICS-UBI - Centro de Investigação em Ciências da Saúde; Universidade da Beira Interior; Av. Infante D. Henrique Covilhã 6200-506 Portugal
| | - João A. Queiroz
- CICS-UBI - Centro de Investigação em Ciências da Saúde; Universidade da Beira Interior; Av. Infante D. Henrique Covilhã 6200-506 Portugal
| | - Carla Cruz
- CICS-UBI - Centro de Investigação em Ciências da Saúde; Universidade da Beira Interior; Av. Infante D. Henrique Covilhã 6200-506 Portugal
| | - Ângela Sousa
- CICS-UBI - Centro de Investigação em Ciências da Saúde; Universidade da Beira Interior; Av. Infante D. Henrique Covilhã 6200-506 Portugal
| |
Collapse
|